| 000 | 01613 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513030358.0 | ||
| 264 | 0 | _c19960118 | |
| 008 | 199601s 0 0 eng d | ||
| 022 | _a0022-3549 | ||
| 024 | 7 |
_a10.1002/jps.2600840805 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRajewski, R A | |
| 245 | 0 | 0 |
_aPreliminary safety evaluation of parenterally administered sulfoalkyl ether beta-cyclodextrin derivatives. _h[electronic resource] |
| 260 |
_bJournal of pharmaceutical sciences _cAug 1995 |
||
| 300 |
_a927-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticoagulants _xtoxicity |
| 650 | 0 | 4 | _aBlood Urea Nitrogen |
| 650 | 0 | 4 | _aChromatography, Thin Layer |
| 650 | 0 | 4 |
_aCyclodextrins _xadministration & dosage |
| 650 | 0 | 4 |
_aDextran Sulfate _xtoxicity |
| 650 | 0 | 4 |
_aErythrocytes _xdrug effects |
| 650 | 0 | 4 |
_aExcipients _xadministration & dosage |
| 650 | 0 | 4 |
_aHemolysis _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 |
_aKidney _xpathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred Strains |
| 650 | 0 | 4 | _aPartial Thromboplastin Time |
| 700 | 1 | _aTraiger, G | |
| 700 | 1 | _aBresnahan, J | |
| 700 | 1 | _aJaberaboansari, P | |
| 700 | 1 | _aStella, V J | |
| 700 | 1 | _aThompson, D O | |
| 773 | 0 |
_tJournal of pharmaceutical sciences _gvol. 84 _gno. 8 _gp. 927-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jps.2600840805 _zAvailable from publisher's website |
| 999 |
_c7499742 _d7499742 |
||